PL3653599T3 - Krystaliczny fosforan tapentadolu - Google Patents

Krystaliczny fosforan tapentadolu

Info

Publication number
PL3653599T3
PL3653599T3 PL19208228.7T PL19208228T PL3653599T3 PL 3653599 T3 PL3653599 T3 PL 3653599T3 PL 19208228 T PL19208228 T PL 19208228T PL 3653599 T3 PL3653599 T3 PL 3653599T3
Authority
PL
Poland
Prior art keywords
tapentadol phosphate
crystalline tapentadol
crystalline
phosphate
tapentadol
Prior art date
Application number
PL19208228.7T
Other languages
English (en)
Inventor
Wolfgang Albrecht
Richard Guserle
Jens Geier
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of PL3653599T3 publication Critical patent/PL3653599T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL19208228.7T 2016-04-19 2017-04-18 Krystaliczny fosforan tapentadolu PL3653599T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP16166101 2016-04-19
EP16166099 2016-04-19
EP16170780 2016-05-23
EP16170781 2016-05-23

Publications (1)

Publication Number Publication Date
PL3653599T3 true PL3653599T3 (pl) 2023-03-20

Family

ID=58537027

Family Applications (3)

Application Number Title Priority Date Filing Date
PL17716933T PL3445742T3 (pl) 2016-04-19 2017-04-18 Krystaliczny fosforan tapentadolu
PL20216224.4T PL3819287T3 (pl) 2016-04-19 2017-04-18 Amorficzny fosforan tapentadolu
PL19208228.7T PL3653599T3 (pl) 2016-04-19 2017-04-18 Krystaliczny fosforan tapentadolu

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL17716933T PL3445742T3 (pl) 2016-04-19 2017-04-18 Krystaliczny fosforan tapentadolu
PL20216224.4T PL3819287T3 (pl) 2016-04-19 2017-04-18 Amorficzny fosforan tapentadolu

Country Status (7)

Country Link
EP (3) EP3653599B1 (pl)
DK (3) DK3653599T3 (pl)
ES (3) ES2772806T3 (pl)
HR (1) HRP20200029T1 (pl)
PL (3) PL3445742T3 (pl)
PT (1) PT3445742T (pl)
WO (1) WO2017182438A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2860676T3 (es) 2010-07-23 2021-10-05 Gruenenthal Gmbh Sales o cocristales de 3- (3-dimetilamino-1-etil-2-metil-propil) -fenol
EP3875079A1 (en) * 2020-03-02 2021-09-08 Grünenthal GmbH Dosage form providing prolonged release of tapentadol phosphoric acid salt
PL3875077T3 (pl) * 2020-03-02 2024-03-11 Grünenthal GmbH Postać dawkowania zapewniająca przedłużone uwalnianie soli kwasu fosforowego tapentadolu
WO2021175773A1 (en) 2020-03-02 2021-09-10 Grünenthal GmbH Dosage form providing prolonged release of tapentadol phosphoric acid salt
AU2020100442B4 (en) * 2020-03-02 2020-06-18 Grünenthal GmbH Dosage form providing prolonged release of tapentadol phosphoric acid salt
ES3060121T3 (en) * 2020-03-02 2026-03-25 Gruenenthal Gmbh Dosage form providing prolonged release of tapentadol phosphoric acid salt
DE202020104285U1 (de) 2020-07-24 2020-12-18 Grünenthal GmbH Ethylcellulose-beschichtete Partikel enthaltend ein Salz aus Tapentadol und Phosphorsäure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DK1612203T3 (da) 2004-06-28 2007-12-03 Gruenenthal Gmbh Krystallinske former af (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenolhydrochlorid
CN101939287B (zh) 2007-12-07 2014-10-22 格吕伦塔尔有限公司 (1r,2r)-3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚的结晶变体
ES2860676T3 (es) 2010-07-23 2021-10-05 Gruenenthal Gmbh Sales o cocristales de 3- (3-dimetilamino-1-etil-2-metil-propil) -fenol
WO2012051246A1 (en) 2010-10-12 2012-04-19 Ratiopharm Gmbh Tapentadol hydrobromide and crystalline forms thereof

Also Published As

Publication number Publication date
WO2017182438A1 (en) 2017-10-26
EP3819287B1 (en) 2023-09-20
EP3653599B1 (en) 2022-12-14
EP3445742A1 (en) 2019-02-27
ES2772806T3 (es) 2020-07-08
DK3653599T3 (da) 2023-01-30
ES2966219T3 (es) 2024-04-19
PT3445742T (pt) 2020-02-19
PL3445742T3 (pl) 2020-05-18
ES2937740T3 (es) 2023-03-30
EP3819287A1 (en) 2021-05-12
EP3653599A1 (en) 2020-05-20
DK3445742T3 (da) 2020-02-24
DK3819287T3 (da) 2023-12-18
HRP20200029T1 (hr) 2020-03-20
EP3445742B1 (en) 2019-11-13
PL3819287T3 (pl) 2024-03-11

Similar Documents

Publication Publication Date Title
IL273730A (en) crystalline forms
GB2546192B (en) Toothbrush orientation system
EP3282830C0 (en) GROWTH SYSTEM
GB2539105B (en) Fastener
PT3445742T (pt) Fosfato de tapentadol cristalino
GB2538772B (en) Beam scheduling
GB2535696B (en) Planter
GB2536673B (en) Evaporator
SG10201911417PA (en) Crystalline compounds
GB201419174D0 (en) Crystalline forms
IL265445A (en) crystalline forms
PL3280242T3 (pl) System obróbki gleby
HUE044938T2 (hu) Talajmûvelõ szerszám
LT3390358T (lt) Kristalinis eravaciklino bis-hidrochloridas
PL3350179T3 (pl) Krystaliczne postacie
GB2537392B (en) Improved evaporator
PT3653599T (pt) Fosfato de tapentadol cristalino
ZA201902553B (en) Crystalline forms
IL261795A (en) Crystalline form
GB201715010D0 (en) Crystalline forms
GB201708856D0 (en) Seletalisib crystalline forms
GB201604759D0 (en) Crystalline compounds
GB201509505D0 (en) Grow houses
HK1260864A1 (en) Crystalline form
GB201502496D0 (en) Localization